Updated August 31 at 6:31pm

Rewarding innovation in vaccine research

A nearly $200,000 grant from the Rhode Island Science and Technology Advisory Council allows researchers, including EpiVax Inc. founder Annie De Groot, above, to continue work on an anti-tick vaccine delivered through the use of a transdermal patch. De Groot has been working with University of Rhode Island researchers on the vaccine, which remains years away from the marketplace. The grant allows Isis Biopolymer Inc. to join in the project, to help develop a delivery system for the vaccine.

To continue reading this article, please do one of the following.



Enter your email to receive Providence Business News' e-newsletters
and breaking news alerts.  

PAGE TWO PHOTO

Rewarding innovation in vaccine research

Posted:

A nearly $200,000 grant from the Rhode Island Science and Technology Advisory Council allows researchers, including EpiVax Inc. founder Annie De Groot, above, to continue work on an anti-tick vaccine delivered through the use of a transdermal patch. De Groot has been working with University of Rhode Island researchers on the vaccine, which remains years away from the marketplace. The grant allows Isis Biopolymer Inc. to join in the project, to help develop a delivery system for the vaccine.

25-46, 022111 , Annie De Groot, technology, public policy, EpiVax Inc., University of Rhode Island, Biopolymer Inc., technology, public policy, 25-46, issue022111export.pbn

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News